Universal Beteiligungs und Servicegesellschaft mbH Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm bought 25,767 shares of the company's stock, valued at approximately $2,277,000.

Several other hedge funds have also recently bought and sold shares of HQY. Versant Capital Management Inc bought a new stake in shares of HealthEquity during the 1st quarter valued at approximately $28,000. Transce3nd LLC acquired a new stake in HealthEquity during the 4th quarter worth approximately $29,000. Larson Financial Group LLC boosted its position in HealthEquity by 1,366.0% during the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after buying an additional 642 shares during the period. Whipplewood Advisors LLC boosted its position in HealthEquity by 5,060.0% during the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after buying an additional 759 shares during the period. Finally, Huntington National Bank boosted its position in HealthEquity by 89.4% during the 4th quarter. Huntington National Bank now owns 767 shares of the company's stock worth $74,000 after buying an additional 362 shares during the period. 99.55% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. The Goldman Sachs Group lifted their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. Royal Bank Of Canada lifted their target price on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Finally, JMP Securities lifted their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $118.55.

HealthEquity Stock Down 6.1%

Shares of HealthEquity stock traded down $5.94 during trading on Friday, reaching $91.06. 1,406,702 shares of the company traded hands, compared to its average volume of 809,118. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The company has a 50 day moving average price of $101.17 and a 200-day moving average price of $98.25. The firm has a market capitalization of $7.87 billion, a PE ratio of 66.47, a P/E/G ratio of 1.50 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the previous year, the company earned $0.80 EPS. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares in the company, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 291,744 shares of company stock worth $32,705,007. Insiders own 1.50% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.